That 2.6 percentage-point gap between 1.0 mg and 2.4 mg represents a meaningful clinical difference, roughly 6 to 7 additional pounds for a 250-pound patient
Of note, location of the proximal catheter in the ventricle or lumbar subarachnoid space was not significantly associated with admission or shunt revision in the multivariable analyses
population isnt getting access to these medications, Scannell says
159(3): 2919 Cederblad G, Carlin JI, Constantin-Teodosiu D, et al
Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1
15% Average Weight Loss People using Ozempic & Wegovy, medications with the active ingredient semaglutide, lost 15% of their body weight on average